| For: | Zhao Y, He GS, Li G. Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature. World J Clin Cases 2023; 11(27): 6558-6564 [PMID: 37900216 DOI: 10.12998/wjcc.v11.i27.6558] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i27/6558.htm |
| Number | Citing Articles |
| 1 |
Yuanjin Ma, Jian Long, Shangbo Shi, Xinyi Fang, Ruidong Wang, Feng Xiong, Hong Ren, Wei Li, Xuexian Zhang. DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1779170
|